{
    "Trade/Device Name(s)": [
        "VITROS Immunodiagnostic Products Anti-HAV Total Reagent Pack",
        "VITROS Immunodiagnostic Products Anti-HAV Total Calibrators",
        "VITROS Immunodiagnostic Products Anti-HAV Total Controls"
    ],
    "Submitter Information": "Ortho-Clinical Diagnostics, Inc.",
    "510(k) Number": "K060678",
    "Predicate Device Reference 510(k) Number(s)": [
        "P780012",
        "BK960085",
        "K962919",
        "K964310",
        "K970894"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LOL"
    ],
    "Summary Letter Date": "September 14, 2006",
    "Summary Letter Received Date": "August 7, 2006",
    "Submission Date": "August 4, 2006",
    "Regulation Number(s)": [
        "21 CFR 866.3310",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Hepatitis A virus (HAV) serological assays",
        "Single (specified) analyte controls (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "serology",
        "virology"
    ],
    "Analyte(s)": [
        "Total antibody to Hepatitis A virus (IgG and IgM)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Heparin tube",
        "Citrate tube"
    ],
    "Instrument(s)/Platform(s)": [
        "VITROS ECi Immunodiagnostic System",
        "VITROS ECiQ Immunodiagnostic System"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay (EIA)",
        "Luminescence-based detection"
    ],
    "Methodologies": [
        "Competitive immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control",
        "Reagent Pack"
    ],
    "Document Summary": "FDA 510(k) summary for VITROS Immunodiagnostic Anti-HAV Total Reagent, Calibrator, and Controls for qualitative detection of HAV antibodies using competitive enzyme immunoassay.",
    "Indications for Use Summary": "Qualitative detection of total antibody (IgG and IgM) to hepatitis A virus in human adult and pediatric serum or plasma as an aid in the diagnosis of acute or past infection and identification of HAV-susceptible individuals prior to vaccination, using the VITROS ECi/ECiQ Immunodiagnostic System.",
    "fda_folder": "Microbiology"
}